Formaldehyde → HCID 86727508, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[CH:21]=[C:20]2[C:11]([N:12]3[C:17]([CH2:18][O:19]2)=[N:16][NH:15][C:14](=[O:22])[C@H:13]3[CH3:23])=[CH:10][C:9]=1[C@H:24]([C:26]1([CH3:30])[CH2:29][NH:28][CH2:27]1)[CH3:25].C=O.[BH3-][C:34]#N.[Na+].C([O-])(O)=O.[Na+]>CC(O)=O.CO>[CH3:34][N:28]1[CH2:29][C:26]([C@@H:24]([C:9]2[CH:10]=[C:11]3[C:20](=[CH:21][C:8]=2[C:3]2[CH:4]=[CH:5][CH:6]=[CH:7][C:2]=2[F:1])[O:19][CH2:18][C:17]2[N:12]3[C@H:13]([CH3:23])[C:14](=[O:22])[NH:15][N:16]=2)[CH3:25])([CH3:30])[CH2:27]1Participants
Procedure
To a solution of (R)-7-(2-fluoro-phenyl)-4-methyl-6-[(R)-1-(3-methyl-azetidin-3-yl)-ethyl]-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one (0.04 g, 0.098 mmol) in AcOH (0.5 mL) and MeOH (5 mL) was added paraformaldehyde (0.029 g, 0.979 mmol) and the resulting mixture was stirred at ambient temperature for 1 h. NaBH3CN (0.015 g, 0.245 mmol) was added and the reaction mixture was stirred at ambient temperature overnight. Aqueous NaHCO3 (10 mL) was added and the aqueous solution was extracted with EtOAc (3×30 mL). The combined organic phase was dried over anhydrous sodium sulfate and filtered. The filtrate was evaporated in vacuo and the residue was purified by prep-HPLC (Table 3, Method 25) to give (R)-6-[(R)-1-(1,3-dimethyl-azetidin-3-yl)-ethyl]-7-(2-fluoro-phenyl)-4-methyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one (0.017 g, 40%). 1H NMR (CD3OD, 400 MHz): δ 7.40-7.48 (m, 1H), 7.15-7.32 (m, 3H), 6.91 (s, 1H), 6.84 (s, 1H), 4.83 (m, 1H), 4.58-4.69 (m, 2H), 2.87-3.19 (m, 3H), 2.73-2.87 (m, 2H), 2.10-2.22 (m, 3H), 1.50 (m, 3H), 1.25-1.35 (m, 3H), 1.13-1.23 (m, 3H). LC/MS (Table 1, Method 4) Rt=1.858 min; MS m/z: 423 [M+H]+. SFC (Table 1, Method 15) Rt=1.592 min.
Workup
- stirringthe reaction mixture was stirred at ambient temperature overnight
- extractionthe aqueous solution was extracted with EtOAc (3×30 mL)
- dry with materialThe combined organic phase was dried over anhydrous sodium sulfate
- filtrationfiltered
- customThe filtrate was evaporated in vacuo
- customthe residue was purified by prep-HPLC (Table 3, Method 25)
Sources & evidence
- ORD record
- ord-2981c556054b4745b7a2574ba0def394
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09115151B2
Reaction notes
Loading…